This move could be indicative of ARK's confidence in the biotechnology sector and Illumina's role within it. Additionally, ARK bought shares of Twist Bioscience Corp (NASDAQ:TWST) valued at $ ...

Our services include study design, library preparation, target enrichment with Twist Biosciences, sequencing on Illumina platform and primary data analysis. We use Illumina DRAGEN for data analysis.

China Bans Imports of Illumina's Gene Sequencers Right After Trump Tariff Action By Andrew Silver SHANGHAI (Reuters) -China announced a ban on Tuesday on imports of genetic sequencers from U.S ...